Epilepsy leadership Empatica’s FDA-cleared EpiMonitor and Embrace platforms position them as a leading partner for epilepsy monitoring trials and real-world data collection, suggesting strong sales opportunities with neurology clinics, research institutions, and pharma companies running epilepsy programs.

Acquisitions scale Recent acquisitions of Global Kinetics and PKG Health expand portfolio into Parkinson’s disease and broader movement disorders, creating cross-sell opportunities with existing customers and opening doors to new neurodegenerative study collaborations.

Clinical trial ready With the Embrace wearables and validated digital biomarkers integrated into a scalable Health Monitoring Platform used by thousands of institutional partners, there is a clear path to contract research organizations and clinical trial sponsors seeking remote monitoring capabilities.

Trial innovation EmbraceMini’s emergence as the smallest actigraphy wearable for trials enhances patient comfort and data quality, enabling life sciences firms to run longer, more compliant studies in diverse populations and settings.

Global reach Operating across the US, Europe, and Asia with multiple offices, Empatica offers global deployment potential for multinational studies, regulatory navigation support, and scalable data capture across diverse patient cohorts.